Clinical Trials Directory

Trials / Conditions / Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8

Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8

8 registered clinical trials studyying Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8 — 1 currently recruiting.

StatusTrialSponsorPhase
Active Not RecruitingTesting the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advance
NCT04391049
NRG OncologyPhase 1
RecruitingNBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer
NCT04615013
M.D. Anderson Cancer CenterPhase 1
Active Not RecruitingA Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma
NCT04111172
Thomas Jefferson UniversityPhase 2
CompletedReal-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study
NCT04449679
Thomas Jefferson UniversityN/A
CompletedRemote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
NCT04501913
City of Hope Medical Center—
CompletedUse of Trifluridine/Tipiracil and Oxaliplatin as Induction Chemotherapy for the Treatment of Resectable Esopha
NCT04097028
Roswell Park Cancer InstitutePhase 2
CompletedCharacterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes
NCT04183218
Mayo Clinic—
Active Not RecruitingPhase I/II Study of Perioperative Chemotherapy Plus Immunotherapy Followed by Surgery in Localized Esophageal
NCT03784326
M.D. Anderson Cancer CenterPhase 2